- Home
- SVT vs ACXP Comparison
SVT vs ACXP Comparison
Compare SVT & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVT
- ACXP
- Stock Information
- Founded
- SVT 1959
- ACXP 2017
- Country
- SVT United States
- ACXP United States
- Employees
- SVT N/A
- ACXP N/A
- Industry
- SVT Industrial Machinery/Components
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- SVT Consumer Discretionary
- ACXP Health Care
- Exchange
- SVT Nasdaq
- ACXP Nasdaq
- Market Cap
- SVT 26.8M
- ACXP 8.4M
- IPO Year
- SVT N/A
- ACXP 2021
- Fundamental
- Price
- SVT N/A
- ACXP $0.49
- Analyst Decision
- SVT
- ACXP Strong Buy
- Analyst Count
- SVT 0
- ACXP 2
- Target Price
- SVT N/A
- ACXP $10.00
- AVG Volume (30 Days)
- SVT 26.4K
- ACXP 18.6M
- Earning Date
- SVT 08-07-2025
- ACXP 08-08-2025
- Dividend Yield
- SVT N/A
- ACXP N/A
- EPS Growth
- SVT N/A
- ACXP N/A
- EPS
- SVT N/A
- ACXP N/A
- Revenue
- SVT $46,174,000.00
- ACXP N/A
- Revenue This Year
- SVT N/A
- ACXP N/A
- Revenue Next Year
- SVT N/A
- ACXP N/A
- P/E Ratio
- SVT N/A
- ACXP N/A
- Revenue Growth
- SVT 2.58
- ACXP N/A
- 52 Week Low
- SVT $9.67
- ACXP $0.30
- 52 Week High
- SVT $47.48
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- SVT 94.92
- ACXP 51.70
- Support Level
- SVT $46.75
- ACXP $0.46
- Resistance Level
- SVT $47.48
- ACXP $0.56
- Average True Range (ATR)
- SVT 0.13
- ACXP 0.10
- MACD
- SVT -1.15
- ACXP -0.01
- Stochastic Oscillator
- SVT 29.87
- ACXP 25.55
About SVT Servotronics Inc.
Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users. Geographically, the company generates the majority of its revenue from the Domestic market.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.